About Avipero
Mission
Avipero is a privately held startup developing a revolutionary new approach to Parkinson's disease and viral haemorrhagic fevers.
Avipero Description
Avipero Ltd (Registered in Scotland SC353945) is a private biopharmaceutical company established in 2009. Avipero is focused on the development of novel therapeutic for unmet clinical needs, characterised by a loss of cells and tissues with proven pre-clinical efficacy in multiple indications. The main indication for Avipero’s R& D is Parkinson’s with Lewy Body Dementia. Avipero has extended its platform in 2013 to include orphan haemorrhagic fever viral indications in partnership with Public Health England.
More about Avipero
Avipero is located at 125 Princes Street, EH2 4AD Edinburgh, United Kingdom
http://www.avipero.com